Corrigendum to "The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A review" [J. Pharma. Anal. 11 (2021) 265-271].

J Pharm Anal

Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.

Published: December 2022

[This corrects the article DOI: 10.1016/j.jpha.2021.03.003.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770015PMC
http://dx.doi.org/10.1016/j.jpha.2022.11.001DOI Listing

Publication Analysis

Top Keywords

corrigendum "the
4
"the potential
4
potential mirna-based
4
mirna-based therapeutics
4
therapeutics severe
4
severe acute
4
acute respiratory
4
respiratory syndrome
4
syndrome coronavirus
4
coronavirus sars-cov-2
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!